Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000596004 | SCV000709368 | uncertain significance | not provided | 2017-06-23 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001037515 | SCV001200931 | pathogenic | Niemann-Pick disease, type B; Niemann-Pick disease, type A | 2024-03-14 | criteria provided, single submitter | clinical testing | This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 184 of the SMPD1 protein (p.Pro184Leu). This variant is present in population databases (rs760203204, gnomAD 0.03%). This missense change has been observed in individuals with SMPD1-related conditions (PMID: 16642440, 17011332). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 502573). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SMPD1 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects SMPD1 function (PMID: 16642440). For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV001037515 | SCV005684497 | likely pathogenic | Niemann-Pick disease, type B; Niemann-Pick disease, type A | 2024-03-19 | criteria provided, single submitter | clinical testing |